Nobuo Kurokawa
- Chemical Health and Safety top 5%
- Occupational Therapy top 5%
- Safe Handling of Antineoplastic Drugs 4
-
- Growth Hormone and Insulin-like Growth Factors 4
- Thyroid Cancer Diagnosis and Treatment 3
-
- Neuropeptides and Animal Physiology 4
-
- Carcinogens and Genotoxicity Assessment 3
-
- Pharmacy and Medical Practices 3
-
- Nausea and vomiting management 2
- Anesthesia and Pain Management 2
- Co-authors
- Yoshihiko HirotaniYoshihiro MiwaYukio ArakawaKaoru YamamotoNobuyuki OhguroYasuo TanoTakuya IkedaNoriyasu Hashida
- Journals
- The Journal of Clinical Endocrinology & Metabolism (2 papers)Annals of the New York Academy of Sciences (1 paper)Carcinogenesis (1 paper)
- Partner nations
- JapanUnited StatesSingapore
In The Last Decade
Nobuo Kurokawa
50 papers receiving 364 citations
Peers
Comparison fields: 5 of 93
- Chemical Health and Safety 14
- Applied Microbiology and Biotechnology 27
- Occupational Therapy 35
- Endocrine and Autonomic Systems 28
- Behavioral Neuroscience 13
Countries citing papers authored by Nobuo Kurokawa
This map shows the geographic impact of Nobuo Kurokawa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nobuo Kurokawa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nobuo Kurokawa more than expected).
Fields of papers citing papers by Nobuo Kurokawa
This network shows the impact of papers produced by Nobuo Kurokawa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nobuo Kurokawa. The network helps show where Nobuo Kurokawa may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Nobuo Kurokawa, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2008 | 2 | |
| 2 | 2008 | 5 | |
| 3 | 2008 | 10 | |
| 4 | 2008 | 8 | |
| 5 | [Comparison of antiemetic efficacy of 5-HT3 receptor antagonists in orthopedics cancer patients receiving high-dose chemotherapy]. | 2007 | 4 |
| 6 | 2007 | 3 | |
| 7 | 2007 | 8 | |
| 8 | 2007 | 19 | |
| 9 | 2006 | 3 | |
| 10 | 2004 | 1 | |
| 11 | 2002 | 5 | |
| 12 | 2001 | 1 | |
| 13 | 2000 | 3 | |
| 14 | Synthesis of Rat Glucagon-Like Peptide (GLP)-2 and Its Biological and Immunochemical Studies | 2000 | 1 |
| 15 | 1996 | 4 | |
| 16 | 1996 | 5 | |
| 17 | 1995 | 2 | |
| 18 | 1990 | 4 | |
| 19 | A Psychosomatic Consideration of Subjective Complaints of Patients with Graves' Disease | 1978 | 1 |
| 20 | Changes of Serum Growth Hormone in Psychosomatic Disorders | 1975 | 1 |
About Nobuo Kurokawa
Nobuo Kurokawa is a scholar working on Chemical Health and Safety, Applied Microbiology and Biotechnology and Occupational Therapy, having authored 52 papers that have together received 385 indexed citations. Recurring topics across this work include Safe Handling of Antineoplastic Drugs (4 papers), Growth Hormone and Insulin-like Growth Factors (4 papers), Neuropeptides and Animal Physiology (4 papers), Carcinogens and Genotoxicity Assessment (3 papers), Pharmacy and Medical Practices (3 papers), Thyroid Cancer Diagnosis and Treatment (3 papers), Nausea and vomiting management (2 papers) and Anesthesia and Pain Management (2 papers). The work is most often cited by research in Chemical Health and Safety (14 citations), Applied Microbiology and Biotechnology (27 citations) and Occupational Therapy (35 citations). Nobuo Kurokawa has collaborated with scholars based in Japan, United States and Singapore. Frequent co-authors include Yoshihiko Hirotani, Yoshihiro Miwa, Yukio Arakawa, Kaoru Yamamoto, Nobuyuki Ohguro, Yasuo Tano, Takuya Ikeda, Noriyasu Hashida, Kazunori Tomono and Shoji Matsumoto. Their work appears in journals such as The Journal of Clinical Endocrinology & Metabolism, Annals of the New York Academy of Sciences and Carcinogenesis.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.